Better Buy: Aurora Cannabis vs. Cronos Group
When it comes to Canadian cannabis companies, Aurora Cannabis (NYSE: ACB) has long had an upper hand. Aurora was already thriving with its medical cannabis business when it began to draw even more attention after the recreational market opened in Canada in 2018. A few major mistakes and external headwinds pulled Aurora to the ground last year, but its recent momentum has brought it back to the spotlight again.
Meanwhile, Cronos Group (NASDAQ: CRON) has been strengthening its balance sheet, and it has put itself in a safe position in the ongoing crisis. So let's shed some light on where you should place your bet.
Image source: Getty Images.
Source Fool.com
